GlassScriptPhysician profile
Evan Sternberg
NPI 1285085902
$9,147.59
in general payments reported to CMS, 2019-2025
27 companies · $2,893 in 2025
The $2,893 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $628 · 2021: $878 · 2022: $814 · 2023: $1,577 · 2024: $2,132 · 2025: $2,893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,685 · Travel and Lodging: $1,872 · Education: $46.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,684.80 |
| Travel and Lodging | $1,871.54 |
| Education | $46.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,998.41 | 2023-2025 | Indigo System |
| Abiomed | $1,778.86 | 2023-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $965.80 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $919.65 | 2020-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $611.71 | 2020-2025 | |
| Shockwave Medical, INC | $424.53 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $420.10 | 2020-2025 | Farxiga, Wainua, Brilinta |
| Merck Sharp & Dohme LLC | $406.43 | 2021-2025 | Verquvo |
| Pfizer INC. | $211.74 | 2019-2024 | |
| Medtronic, INC. | $197.46 | 2021-2025 | Linq II, Azure Xt Dr Mri Surescan, Claria Mri Quad Crt-D Surescan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $156.05 | 2021-2025 | Jardiance |
| Amgen INC. | $134.84 | 2020-2024 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $116.86 | 2025 | |
| Cardiovascular Systems INC. | $113.93 | 2019-2021 | |
| Teleflex LLC | $107.87 | 2023-2025 | Guideliner |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $103.01 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $91.78 | 2022-2025 | Camzyos |
| Chiesi USA, INC. | $72.00 | 2023 | Kengreal |
| Lexicon Pharmaceuticals, INC. | $56.99 | 2023-2024 | Inpefa |
| Abbott Laboratories | $46.63 | 2022-2023 | Perclose Proglide |
| Cook Medical LLC | $44.84 | 2020-2024 | Icast Covered Stent System, 6mmx22mmx120cm |
| Inari Medical, INC. | $38.39 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astellas Pharma US INC | $35.94 | 2019-2021 | |
| Esperion Therapeutics, INC. | $35.67 | 2021-2024 | Nexletol |
| Stryker Corporation | $23.94 | 2025 | Artix Mt |
| Boston Scientific Corporation | $22.61 | 2023 | Ekosonic |
| Lantheus Medical Imaging, INC. | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Sternberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.